40 completed, 13 unknown, 11 recruiting, 5 active not recruiting. 32 Phase 2, 22 Phase 1, 17 Not applicable, 6 Early Phase 1, 4 Phase 4.
Follow Quercetin: new trials by email Literature Review of Quercetin trials Research Report on Quercetin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients green tea and quercetin + docetaxel, Placebo + docetaxel - Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 1 / Phase 2 | Recruiting | Charles Drew University of Medicine and Science | 99 | 2026-10-01 | 2026-04-15 |
| The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health Quercetin (dietary supplement), Coenzyme Q10, Rice Flour - Healthy Aging, Inflammaging | Not applicable | Recruiting | Applied Science & Performance Institute | 60 | 2026-09-18 | 2026-09-17 |
| Palmitic Acid and Human Microvascular Function Quercetin (dietary supplement), Placebo - Microvascular Dysfunction, Microvasculature | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 40 | 2026-07-01 | 2026-04-29 |
| Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD) Quercetin - Dyskeratosis Congenita, Telomere Disease | Phase 1 | Recruiting | Children's Hospital Medical Center, Cincinnati | 12 | 2026-05-29 | 2026-09-10 |
| Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency Quercetin - XIAP Deficiency | Phase 1 | Recruiting | Children's Hospital Medical Center, Cincinnati | 12 | 2026-02-26 | 2026-03-27 |
| Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. Quercetin (dietary supplement), Usual treatment - Fibrotic Interstitial Lungs Diseases, Idiopathic Pulmonary Fibrosis (IPF) | Not applicable | Recruiting | Katerina M. Antoniou | 100 | 2026-01-26 | 2026-03-12 |
| Senolytics for Secondary Progressive MS Dasatinib and quercetin - Multiple Sclerosis (MS) Secondary Progressive | Phase 1 | Not yet recruiting | Ohio State University | 30 | 2026-01-15 | 2025-12-08 |
| Improving Physical Ability and Cellular Senescence Elimination in HIV Dasatinib, Quercetin, Placebo - Dasatinib - HIV, Frailty | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 82 | 2025-12-04 | 2026-09-15 |
| Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). resveratrol, quercetin, taurine, whey protein, and inulin, whey protein - Liver Disease Chronic, HEPATITIS C VIRUS CHRONIC INFECTION | Not applicable | Recruiting | University of Guadalajara | 26 | 2025-10-11 | 2026-03-23 |
| Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome Quercetin, Alpha Lipoic Acid 600 MG Oral Tablet, MetFORMIN 500 Mg Oral Tablet - PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Phase 2 | Recruiting | Al-Mustansiriyah University | 150 | 2025-09-20 | 2025-09-19 |
| Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Recruiting | Mayo Clinic | 44 | 2025-09-18 | 2026-08-26 |
| Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease Biospecimen Collection, Dasatinib, Fisetin - Glioma | Early Phase 1 | Recruiting | Mayo Clinic | 30 | 2025-08-12 | 2026-10-01 |
| Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study Risk managment, Dasatinib, Quercetin (dietary supplement) - Aging, Cognitive Decline | Phase 2 | Completed | Washington University School of Medicine | 23 | 2025-07-28 | 2026-08-19 |
| Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms Nasafytol® (Quercetin/Curcumin Supplement) - Long COVID | Not applicable | Completed | Liaquat University of Medical & Health Sciences | 15 | 2025-07-22 | 2025-12-19 |
| The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic Rhinitis Quercetin, Apple Extract, Loratadine 10 Mg - Rhinitis, Allergic, Perennial | Not applicable | Completed | Universitas Sebelas Maret | 40 | 2025-04-01 | 2026-02-02 |
| Quercetin Effect on Post-ceserean Pain Quercetin, Placebo - Post Operative Pain, Cesarean Section Complications | Phase 3 | Completed | Future University in Egypt | 80 | 2024-10-30 | 2025-02-05 |
| RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β Resveratrol, Quercetin, and Curcumin (RQC), Curcumin - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Not yet recruiting | Zaparackas and Knepper LTD | 200 | 2024-07-01 | 2024-06-26 |
| Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer Quercetin, Dasatinib, Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum - Triple-negative Breast Cancer | Phase 2 | Unknown | Fudan University | 10 | 2024-05-20 | 2024-07-08 |
| Effects of Quercetin on Cardiometabolic Outcomes Quercetin, Placebo - Cardiometabolic Syndrome | Not applicable | Recruiting | University of Central Lancashire | 40 | 2024-03-01 | 2026-09-10 |
| Effect of Quercetin in Treatment of Periodontitis Quercetin, scaling and root planing - Inflammation Gum | Phase 1 | Unknown | Assiut University | 20 | 2024-02-20 | 2024-01-31 |
Showing 20 of 77. Sign in to see all of them.
Alzheimer Disease (5) · Cognitive Dysfunction (5) · Inflammation (5) · COVID-19 (3) · Coronary Artery Disease (3) · Frailty (3) · Obesity (3) · Pulmonary Disease, Chronic Obstructive (3) · Diabetes Mellitus, Type 2 (2) · Emphysema (2) · Fanconi Anemia (2) · Hyperglycemia (2) · Hypertension (2) · Idiopathic Pulmonary Fibrosis (2) · Prostatic Neoplasms (2)
Children's Hospital Medical Center, Cincinnati (4) · Mayo Clinic (4) · Washington University School of Medicine (3) · Assiut University (2) · Hôpital Universitaire Sahloul (2) · InCor Heart Institute (2) · Liaquat University of Medical & Health Sciences (2) · Mashhad University of Medical Sciences (2) · Ministry of Health, Saudi Arabia (2) · Temple University (2) · University of Michigan (2) · Wake Forest University Health Sciences (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Al-Mustansiriyah University (1) · Applied Science & Performance Institute (1)
United States (44) · Egypt (3) · Iran (3) · Netherlands (3) · Brazil (2) · China (2) · Greece (2) · Italy (2) · Tunisia (2) · Canada (1) · Denmark (1) · Indonesia (1) · Iraq (1) · Kazakhstan (1) · Mexico (1)
Eric Lenze, MD (2) · Nicolas Musi, MD (2) · Parinda Mehta, MD (2) · Paul A Knepper, MD, PhD (2) · Riadh Boukef, professor (2) · Aalt Bast, PhD (1) · Adel A. Gomaa, Ph.D. (1) · Agnes W Boots, PhD (1) · Ahmed Mortada Fikry, professor (1) · Antonio P Mansur, PhD (1) · Arai Tolemisova, PhD (1) · Edwin Lee, MD (1) · Farzaneh Sorond, mD, PhD (1) · Fernando J Martinez, M.D. (1) · Ghazaleh Eslamian, PhD (1)
PMID 32071149, PMID 20920189, PMID 22465313, PMID 26621580, PMID 29975735, PMID 34366147, PMID 34687726, PMID 40009460, PMID 19638084, PMID 21324570, PMID 22419935, PMID 23688534, PMID 25311610, PMID 25577300, PMID 25934864, PMID 25972527, PMID 28097231, PMID 28820468, PMID 29105115, PMID 29676998, PMID 29779170, PMID 30136291, PMID 30285386, PMID 30328058, PMID 30398646, PMID 30596641, PMID 30616998, PMID 32615072, PMID 33227231, PMID 33234158, PMID 33278625, PMID 33293006, PMID 33389725, PMID 34746258, PMID 34965513, PMID 35098970, PMID 37437986, PMID 37546740, PMID 37679434, PMID 38468259, PMID 38496619, PMID 38956196, PMID 39032786, PMID 39820512, PMID 39823170, PMID 39990611, PMID 40053115, PMID 40248131, PMID 40274471, PMID 40375481
R33AT009991 (2), K23AG030967 (1), P30CA016056 (1), P50CA186781 (1), R01AG075684 (1), R01DK090794 (1), R03CA171583 (1), R21AT007357 (1), R21DK097529 (1), U01CA246510 (1), U54MD007598 (1)